ID: ALA2017004

Max Phase: Preclinical

Molecular Formula: C16H22N8O6S

Molecular Weight: 454.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NS(=O)(=O)OC[C@H]1O[C@@H](n2cnc3c(NCCCn4ccnc4)ncnc32)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C16H22N8O6S/c17-31(27,28)29-6-10-12(25)13(26)16(30-10)24-9-22-11-14(20-7-21-15(11)24)19-2-1-4-23-5-3-18-8-23/h3,5,7-10,12-13,16,25-26H,1-2,4,6H2,(H2,17,27,28)(H,19,20,21)/t10-,12-,13-,16-/m1/s1

Standard InChI Key:  VICUUFDPYRTNGN-XNIJJKJLSA-N

Associated Targets(Human)

SUMO-activating enzyme 861 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Ubiquitin-like modifier-activating enzyme 5 22 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 454.47Molecular Weight (Monoisotopic): 454.1383AlogP: -1.64#Rotatable Bonds: 9
Polar Surface Area: 192.53Molecular Species: NEUTRALHBA: 13HBD: 4
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.30CX Basic pKa: 6.53CX LogP: -2.34CX LogD: -2.38
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.27Np Likeness Score: -0.15

References

1. Lukkarila JL, da Silva SR, Ali M, Shahani VM, Xu GW, Berman J, Roughton A, Dhe-Paganon S, Schimmer AD, Gunning PT..  (2011)  Identification of NAE Inhibitors Exhibiting Potent Activity in Leukemia Cells: Exploring the Structural Determinants of NAE Specificity.,  (8): [PMID:24900352] [10.1021/ml2000615]

Source